查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433599

美國醫療設備製造商市場規模、佔有率、趨勢分析報告：按應用和細分市場預測，2024-2030

U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application (Orthopedic, Cardiovascular, Neurology, Drug Delivery, Ophthalmic, Nephrology and Urology Devices) And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

美國醫療設備製造商市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，美國醫療設備製造商市場規模預計將達到3,601億美元，複合年成長率為5.8%。

該區域市場主要是由該國高額醫療保健支出推動的。預計老年人口的增加和慢性病盛行率的上升也將促進預測期內的市場成長。

COVID-19 大流行引發了對手套、注射器、口罩、個人防護裝備、紅外線套件、脈搏體溫計脈動式血氧監測儀系統和檢測套組等醫療消耗品和病患輔助用具輔助用品的需求急劇增加。這為現有參與者和新進入者創造了巨大的商機。然而，疫情也導致減重手術、關節重建手術和整容手術等擇期手術大幅減少，限制了上述手術中使用的醫療設備的成長。從2021年中期開始，由於政府積極努力重啟擇期手術，市場預計將復甦。

在美國，醫療設備研發投入不斷加大，尖端技術採用率較高，為醫療設備製造商創造了理想的商業環境。該國擴大採用微創手術也推動了市場的發展。此外，由於意外事故以及久坐生活方式引起的疾病而導致的病例增加，將推動預測期內的市場成長。

美國有優惠的報銷政策，例如美國的醫療保險制度。波士頓科學公司 (Boston Scientific Corp.) 與醫療保險和醫療補助服務 (CMS) 合作，為屬於流動支付分類 (APC) 的 C 代碼涵蓋的所有設備提供報銷。儘管這種有利的報銷結構預計將促進市場成長，但法規不斷變化的性質可能會受到突然修訂的影響，這可能會對市場產生重大影響。

美國醫療設備製造商市場報告亮點

  • 到2023年，給藥裝置將佔據壓倒性的市場佔有率，達到28.2%。影響估計佔有率的因素包括患者便利性和依從性、慢性病盛行率上升、改善疾病管理的技術進步以及老年人口的不斷成長。
  • 2023 年 3 月，美國大學科學家團隊開發了一種新的藥物傳遞技術，有望幫助對抗鴉片類藥物流行、改善癌症治療和改善復健醫學。
  • 行業領導者不斷增加的策略性舉措也推動了市場成長
  • 2023年，美敦力和DaVita Inc.宣布成立Mozarc Medical。該公司的目標是為腎臟健康創造解決方案。
  • 此外，2023年，GE醫療與生物醫學高級研究與開發局簽署了價值4,400萬美元的合約。根據協議，GE 將提供診斷和影像解決方案來治療創傷。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國醫療設備製造商市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國醫療設備製造商的市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國醫療設備製造商市場：應用預估與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 美國醫療設備製造商按應用市場前景

第5章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • Key company market share analysis, 2023
    • Stryker
    • Cardinal Health
    • Eli Lily and Company
    • Intuitive Surgical
    • Edwards Lifesciences Corporation
    • BD
    • Danaher
    • 3M
    • Abbott
    • Baxter
    • B. Braun SE
    • GE HealthCare
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Boston Scientific Corporation
Product Code: GVR-3-68038-032-3

U.S. Medical Device Manufacturers Market Growth & Trends:

The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030 and is projected to expand at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

U.S. Medical Device Manufacturers Market Report Highlights:

  • Drug delivery devices held a dominant market share of 28.2% in 2023. Factors responsible for the estimated share include patient convenience and compliance, rising prevalence of chronic diseases, technological advancements to improve disease management, and increasing geriatric population.
  • In March 2023, a team of scientists at Northwestern University, U.S., developed a novel drug-delivery technology that is expected to have implications for the opioid epidemic and cancer treatment and to improve rehabilitation care.
  • The growing strategic initiative by industry leaders is also driving market growth
  • In 2023, Medtronic and DaVita Inc. announced the launch of a new company, Mozarc Medical. The company aims to create solutions for kidney health.
  • Furthermore, in 2023, GE HealthCare signed a USD 44 million contract with the Biomedical Advanced Research and Development Authority. Within this contract, GE is expected to provide diagnostic and imaging solutions to treat traumatic injuries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing geriatric population
      • 3.2.1.2. High adoption of minimally invasive procedures
      • 3.2.1.3. Increase in the number of sports and road accidents
      • 3.2.1.4. Increasing geographic reach of market players
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Increase in the number of product recalls
      • 3.2.2.2. Social and ethical issues
      • 3.2.2.3. Slow approval procedures
  • 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Orthopedic Devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Cardiovascular Devices
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Neurology Devices
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Drug Delivery Devices
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.5. Ophthalmic Devices
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.6. Nephrology and Urology Devices
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. Key company market share analysis, 2023
    • 5.3.2. Stryker
      • 5.3.2.1. Company overview
      • 5.3.2.2. Financial performance
      • 5.3.2.3. Product benchmarking
      • 5.3.2.4. Strategic initiatives
    • 5.3.3. Cardinal Health
      • 5.3.3.1. Company overview
      • 5.3.3.2. Financial performance
      • 5.3.3.3. Product benchmarking
      • 5.3.3.4. Strategic initiatives
    • 5.3.4. Eli Lily and Company
      • 5.3.4.1. Company overview
      • 5.3.4.2. Financial performance
      • 5.3.4.3. Product benchmarking
      • 5.3.4.4. Strategic initiatives
    • 5.3.5. Intuitive Surgical
      • 5.3.5.1. Company overview
      • 5.3.5.2. Financial performance
      • 5.3.5.3. Product benchmarking
      • 5.3.5.4. Strategic initiatives
    • 5.3.6. Edwards Lifesciences Corporation
      • 5.3.6.1. Company overview
      • 5.3.6.2. Financial performance
      • 5.3.6.3. Product benchmarking
      • 5.3.6.4. Strategic initiatives
    • 5.3.7. BD
      • 5.3.7.1. Company overview
      • 5.3.7.2. Financial performance
      • 5.3.7.3. Product benchmarking
      • 5.3.7.4. Strategic initiatives
    • 5.3.8. Danaher
      • 5.3.8.1. Company overview
      • 5.3.8.2. Financial performance
      • 5.3.8.3. Product benchmarking
      • 5.3.8.4. Strategic initiatives
    • 5.3.9. 3M
      • 5.3.9.1. Company overview
      • 5.3.9.2. Financial performance
      • 5.3.9.3. Product benchmarking
      • 5.3.9.4. Strategic initiatives
    • 5.3.10. Abbott
      • 5.3.10.1. Company overview
      • 5.3.10.2. Financial performance
      • 5.3.10.3. Product benchmarking
      • 5.3.10.4. Strategic initiatives
    • 5.3.11. Baxter
      • 5.3.11.1. Company overview
      • 5.3.11.2. Financial performance
      • 5.3.11.3. Product benchmarking
      • 5.3.11.4. Strategic initiatives
    • 5.3.12. B. Braun SE
      • 5.3.12.1. Company overview
      • 5.3.12.2. Financial performance
      • 5.3.12.3. Product benchmarking
      • 5.3.12.4. Strategic initiatives
    • 5.3.13. GE HealthCare
      • 5.3.13.1. Company overview
      • 5.3.13.2. Financial performance
      • 5.3.13.3. Product benchmarking
      • 5.3.13.4. Strategic initiatives
    • 5.3.14. Johnson & Johnson Services, Inc.
      • 5.3.14.1. Company overview
      • 5.3.14.2. Financial performance
      • 5.3.14.3. Product benchmarking
      • 5.3.14.4. Strategic initiatives
    • 5.3.15. Medtronic
      • 5.3.15.1. Company overview
      • 5.3.15.2. Financial performance
      • 5.3.15.3. Product benchmarking
      • 5.3.15.4. Strategic initiatives
    • 5.3.16. Boston Scientific Corporation
      • 5.3.16.1. Company overview
      • 5.3.16.2. Financial performance
      • 5.3.16.3. Product benchmarking
      • 5.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
  • Table 4 Key companies undergoing acquisitions/expansions
  • Table 5 Key companies undergoing product launch/approval
  • Table 6 Key companies undergoing partnership & collaboration

List of Figures

  • Fig. 1 U.S. Medical Device Manufacturers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Competitive landscape
  • Fig. 9 Market Dynamics
  • Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
  • Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
  • Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
  • Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2023 & 2030
  • Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
  • Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
  • Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
  • Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
  • Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
  • Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market, 2018 - 2030 (USD Billion)
  • Fig. 21 Key company categorization
  • Fig. 22 Heat map analysis
  • Fig. 23 U.S orthopedic devices market share analysis, 2023
  • Fig. 24 U.S cardiac care devices market share analysis, 2023
  • Fig. 25 U.S drug delivery devices market share analysis, 2023
  • Fig. 26 Strategic framework